BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 18444790)

  • 1. Population seroprevalence of human papillomavirus types 6, 11, 16, and 18 in men, women, and children in Australia.
    Newall AT; Brotherton JM; Quinn HE; McIntyre PB; Backhouse J; Gilbert L; Esser MT; Erick J; Bryan J; Formica N; MacIntyre CR
    Clin Infect Dis; 2008 Jun; 46(11):1647-55. PubMed ID: 18444790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The seroprevalence of IgG antibodies to human papillomavirus (HPV) types HPV-16, HPV-18, and HPV-11 capsid-antigens in mothers and their children.
    Marais DJ; Sampson CC; Urban MI; Sitas F; Wiliamson AL
    J Med Virol; 2007 Sep; 79(9):1370-4. PubMed ID: 17607783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of human papillomavirus antibodies in males and females in England.
    Desai S; Chapman R; Jit M; Nichols T; Borrow R; Wilding M; Linford C; Lowndes CM; Nardone A; Pebody R; Soldan K
    Sex Transm Dis; 2011 Jul; 38(7):622-9. PubMed ID: 21317688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence of human papillomavirus types 16 and 18 in the general population in Taiwan: implication for optimal age of human papillomavirus vaccination.
    Chen CJ; Viscidi RP; Chuang CH; Huang YC; Chiu CH; Lin TY
    J Clin Virol; 2007 Feb; 38(2):126-30. PubMed ID: 17210269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroprevalence of HPV vaccine types 6, 11, 16 and 18 in HIV-infected women from South Africa, Brazil and Botswana.
    Firnhaber C; Evans D; Friedman-Khalili R; Willliams S; Michelow P; Matlhagela K; Wester C; Grinsztejn B; Lockman S
    J Clin Virol; 2011 Nov; 52(3):265-8. PubMed ID: 21908233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HPV 6/11, 16, 18 seroprevalence in men in two US cities.
    Dunne EF; Nielson CM; Hagensee ME; Papenfuss MR; Harris RB; Herrel N; Gourlie J; Abrahamsen M; Markowitz LE; Giuliano AR
    Sex Transm Dis; 2009 Nov; 36(11):671-4. PubMed ID: 19809385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence of human papillomavirus type 16 infection in the United States.
    Stone KM; Karem KL; Sternberg MR; McQuillan GM; Poon AD; Unger ER; Reeves WC
    J Infect Dis; 2002 Nov; 186(10):1396-402. PubMed ID: 12404154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence of human papillomavirus type 16 in children.
    Dunne EF; Karem KL; Sternberg MR; Stone KM; Unger ER; Reeves WC; Markowitz LE
    J Infect Dis; 2005 Jun; 191(11):1817-9. PubMed ID: 15871113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroepidemiology of infection with human papillomavirus 16, in men and women attending sexually transmitted disease clinics in the United States.
    Thompson DL; Douglas JM; Foster M; Hagensee ME; Diguiseppi C; BarĂ³n AE; Cameron JE; Spencer TC; Zenilman J; Malotte CK; Bolan G; Kamb ML; Peterman TA;
    J Infect Dis; 2004 Nov; 190(9):1563-74. PubMed ID: 15478060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and predictors of human papillomavirus-6, -11, -16, and -18 infection in young norwegian women.
    Kim S; Arduino JM; Roberts CC; Marsico M; Liaw KL; Skjeldestad FE
    Sex Transm Dis; 2011 Jul; 38(7):587-97. PubMed ID: 21301390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for cutaneous human papillomavirus seroreactivity among patients undergoing skin cancer screening in Florida.
    Iannacone MR; Michael KM; Giuliano AR; Waterboer T; Pawlita M; Rollison DE
    J Infect Dis; 2010 Mar; 201(5):760-9. PubMed ID: 20105078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroprevalence of human papillomavirus types 6, 11, 16 and 18 in Chinese women.
    Ji J; Sun HK; Smith JS; Wang H; Esser MT; Hu S; Pretorius RG; Chen W; Belinson JL; Qiao YL
    BMC Infect Dis; 2012 Jun; 12():137. PubMed ID: 22715915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seroprevalence of HPV vaccine types 6, 11, 16 and 18 in HIV-infected and uninfected women from Brazil.
    Nicol AF; Grinsztejn B; Friedman RK; Veloso VG; Cunha CB; Georg I; Pilotto JH; Moreira RI; Castro CA; Silver B; Viscidi RP
    J Clin Virol; 2013 Jun; 57(2):147-51. PubMed ID: 23490398
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seroepidemiology of human papillomavirus type 11 in the United States: results from the third National Health And Nutrition Examination Survey, 1991--1994.
    Hariri S; Dunne EF; Sternberg M; Unger ER; Meadows KS; Karem KL; Markowitz LE
    Sex Transm Dis; 2008 Mar; 35(3):298-303. PubMed ID: 18091027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-specific HPV seroprevalence among young females in The Netherlands.
    Kramer M; Mollema L; Smits G; Boot H; de Melker H; van der Klis F
    Sex Transm Infect; 2010 Dec; 86(7):494-9. PubMed ID: 20519252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroprevalence of human papillomavirus types 6, 11, 16, and 18 in the United States: National Health and Nutrition Examination Survey 2003-2004.
    Markowitz LE; Sternberg M; Dunne EF; McQuillan G; Unger ER
    J Infect Dis; 2009 Oct; 200(7):1059-67. PubMed ID: 19719390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroprevalence and risk factors for human papillomavirus in Taiwan.
    Wang IJ; Viscidi R; Hwang KC; Lin TY; Chen CJ; Huang LM; Chen HH; Chen CJ
    J Trop Pediatr; 2008 Feb; 54(1):14-8. PubMed ID: 17984124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevaccine era human papillomavirus types 6, 11, 16 and 18 seropositivity in the U.S.A., National Health and Nutrition Examination Surveys, 2003-2006.
    Introcaso CE; Dunne EF; Hariri S; Panicker G; Unger ER; Markowitz LE
    Sex Transm Infect; 2014 Sep; 90(6):505-8. PubMed ID: 24748563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic responses following administration of a vaccine targeting human papillomavirus Types 6, 11, 16, and 18.
    Villa LL; Ault KA; Giuliano AR; Costa RL; Petta CA; Andrade RP; Brown DR; Ferenczy A; Harper DM; Koutsky LA; Kurman RJ; Lehtinen M; Malm C; Olsson SE; Ronnett BM; Skjeldestad FE; Steinwall M; Stoler MH; Wheeler CM; Taddeo FJ; Yu J; Lupinacci L; Railkar R; Marchese R; Esser MT; Bryan J; Jansen KU; Sings HL; Tamms GM; Saah AJ; Barr E
    Vaccine; 2006 Jul; 24(27-28):5571-83. PubMed ID: 16753240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and stability of antibodies to 37 human papillomavirus types--a population-based longitudinal study.
    Antonsson A; Green AC; Mallitt KA; O'Rourke PK; Pandeya N; Pawlita M; Waterboer T; Neale RE
    Virology; 2010 Nov; 407(1):26-32. PubMed ID: 20723959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.